ARCHIVES

Tyrosine Kinase Inhibitor Encoraging For NSCLC

This article is from The Cancer Letter archive.

Vol. 24 No. 7 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

DeVita On Problems Of Drug Response: There May be Tw Populations Of Cells; Molecular Medicine will Change Treatment

December 13, 1991

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005

TA To Release Report On Burton Therapy Requested By Congress

February 9, 1990

In Brief: NCAB Okays Columbia As 21st Comprehensive Cancer Center; GA Probes Cancer Control

February 23, 1979

M.D. Anderson, Madrid In Joint Program

September 2, 1988

Drug Bills Cut $500 Million From Cancer Care, ASCO Says.

July 4, 2003